Astrin is highly expressed in several cancers and it is considered a poor prognostic marker (Yuan et al., 2014; Abdel-Fatah et al., 2016; Bertucci et al., 2016; Zhou et al., 2018; Ying et al., 2020). This evidence concerns the gene SPAG5 and cancer.